These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14379192)

  • 1. Experimental treatment of tumors in mice.
    TURNER FC
    Cancer Res; 1955; Suppl. 2():339-62. PubMed ID: 14379192
    [No Abstract]   [Full Text] [Related]  

  • 2. Test of compounds against certain mouse tumors and leukemias.
    SKIPPER HE; THOMSON JR
    Cancer Res; 1955; Suppl. 2():147-77. PubMed ID: 14379189
    [No Abstract]   [Full Text] [Related]  

  • 3. Tests of compounds against various mouse tumors.
    TARNOWSKI GS
    Cancer Res; 1955; Suppl. 2():333-8. PubMed ID: 14379191
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy studies on transplanted mouse tumors.
    FREEDLANDER BL
    Cancer Res; 1955; Suppl. 2():55-72. PubMed ID: 14379181
    [No Abstract]   [Full Text] [Related]  

  • 5. Tests of compounds against sarcoma 180 in a screening project in mice.
    FIELD JB
    Cancer Res; 1955; Suppl. 2():3-52. PubMed ID: 14379179
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.
    Kudo-Saito C; Schlom J; Camphausen K; Coleman CN; Hodge JW
    Clin Cancer Res; 2005 Jun; 11(12):4533-44. PubMed ID: 15958639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental therapy of HPV16 induced tumors with IL12 expressed by recombinant vaccinia virus in mice.
    Nemeckova S; Sroller V; Hainz P; Krystofova J; Smahel M; Kutinova L
    Int J Mol Med; 2003 Nov; 12(5):789-96. PubMed ID: 14533011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEGATIVE data from experimental cancer chemotherapy studies. II.
    Cancer Res; 1955; Suppl. 2():1-397. PubMed ID: 14379177
    [No Abstract]   [Full Text] [Related]  

  • 10. Sarcoma 180 inhibition screening data.
    STOCK CC; CLARKE DA; PHILIPS FS; BARCLAY RK
    Cancer Res; 1955; Suppl. 2():179-331. PubMed ID: 14379190
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with mouse sarcoma 180.
    WEST D
    Cancer Res; 1955; Suppl. 2():363. PubMed ID: 14379193
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition screening data using sarcoma 180 and adenocarcinoma E0771.
    GOODSON LH; BARVICK L; STONE RG; IBACH M; PALMER J
    Cancer Res; 1955; Suppl. 2():81-102. PubMed ID: 14379183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamic tests of wulong kangai on transplantable tumors in mice].
    Liu YQ; Li CH; Yang GL; Chen H
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1689-91. PubMed ID: 16400950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies with a squamous cell stomach carcinoma of the mouse.
    ARGUS MF
    Cancer Res; 1955; Suppl. 2():1-2. PubMed ID: 14379178
    [No Abstract]   [Full Text] [Related]  

  • 16. Tests of compounds against the Ehrlich ascites tumor.
    FURST A; CUTTING WC
    Cancer Res; 1955; Suppl. 2():73-80. PubMed ID: 14379182
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.
    Hamann PR; Hinman LM; Beyer CF; Greenberger LM; Lin C; Lindh D; Menendez AT; Wallace R; Durr FE; Upeslacis J
    Bioconjug Chem; 2005; 16(2):346-53. PubMed ID: 15769088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.